Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) FCF Margin (2019 - 2026)

Sanofi's FCF Margin history spans 9 years, with the latest figure at 16.01% for Q1 2026.

  • On a quarterly basis, FCF Margin fell 514.0% to 16.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 45.52%, a 425.0% decrease, with the full-year FY2025 number at 16.53%, up 220.0% from a year prior.
  • FCF Margin hit 16.01% in Q1 2026 for Sanofi, up from 112.44% in the prior quarter.
  • Over the last five years, FCF Margin for SNY hit a ceiling of 152.8% in Q4 2024 and a floor of 112.44% in Q4 2025.
  • Historically, FCF Margin has averaged 27.27% across 5 years, with a median of 21.88% in 2025.
  • Biggest five-year swings in FCF Margin: surged 12697bps in 2024 and later crashed -26524bps in 2025.
  • Tracing SNY's FCF Margin over 5 years: stood at 102.31% in 2022, then plummeted by -75bps to 25.83% in 2023, then soared by 492bps to 152.8% in 2024, then plummeted by -174bps to 112.44% in 2025, then soared by 114bps to 16.01% in 2026.
  • Business Quant data shows FCF Margin for SNY at 16.01% in Q1 2026, 112.44% in Q4 2025, and 22.6% in Q3 2025.